EUVIMEDEUVIMED entdecken
Crossref

Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study

Julia Wang, Yajuan Gao iD, Spears M Grant, Steven R Hwang iD, Urshila Durani iD, Gita Thanarajasingam, Arushi Khurana, Jonas Paludo iD, Yucai Wang iD, Grzegorz S Nowakowski, Thomas M Habermann iD, Thomas E Witzig iD und 2 weitere

British Journal of Haematology · 2026-11 · 209 (5) · 2307-2311

DOI: 10.1111/bjh.70776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 01.09.2026. Verfasst von Julia Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study used data from the National Cancer Database (NCDB), a hospital-based, de-identified oncology registry jointly sponsored by the American College of Surgeons and the Commission on Cancer. The NCDB data are available to qualified investigators through an application process and Institutional Review Board approval; individual patient-level data are not publicly accessible. Table S1. Baseline characteristics of patients with classical Hodgkin lymphoma stratified by era of diagnosis. Table S2. Five-year survival rates by era across different patient subgroups. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Schlagwörter

Stichwörter der Autor:innen

classical Hodgkin lymphomaprognostic outcomessurvivaltreatment

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Yajuan Gao, Steven R Hwang, Urshila Durani, Jonas Paludo, Yucai Wang, Thomas M Habermann, Thomas E Witzig, Stephen M Ansell, Jithma P Abeykoon

Zitieren

APA

Wang, J., Gao, Y., Grant, S. M., Hwang, S. R., Durani, U., Thanarajasingam, G., Khurana, A., Paludo, J., Wang, Y., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Ansell, S. M., & Abeykoon, J. P. (2026). Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study. British Journal of Haematology, 209(5), 2307-2311. https://doi.org/10.1111/bjh.70776

Vancouver

Wang J, Gao Y, Grant SM, Hwang SR, Durani U, Thanarajasingam G, et al. Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study. British Journal of Haematology. 2026;209(5):2307-2311. doi:10.1111/bjh.70776

BibTeX
@article{Wang2026,
  author = {Wang, Julia and Gao, Yajuan and Grant, Spears M and Hwang, Steven R and Durani, Urshila and Thanarajasingam, Gita and Khurana, Arushi and Paludo, Jonas and Wang, Yucai and Nowakowski, Grzegorz S and Habermann, Thomas M and Witzig, Thomas E and Ansell, Stephen M and Abeykoon, Jithma P},
  title = {Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2307--2311},
  doi = {10.1111/bjh.70776}
}
Kostenlos starten →